Ann Arbor Stage I Hodgkin Lymphoma

Oncology

Prevalence

56.0 / 100K

Incidence

19.6 / 100K/yr

4 drugs in development·1 company·1 clinical trial

Drug Pipeline by Phase

Compare drugs

Brentuximab Vedotin vs DacarbazineBrentuximab Vedotin vs Enfortumab vedotinBrentuximab Vedotin vs Vinblastine

Frequently asked questions

How many drugs are in development for Ann Arbor Stage I Hodgkin Lymphoma?

BioSniper tracks 4 drugs in development for Ann Arbor Stage I Hodgkin Lymphoma across 1 company.

How many clinical trials target Ann Arbor Stage I Hodgkin Lymphoma?

There are 1 clinical trial targeting Ann Arbor Stage I Hodgkin Lymphoma tracked by BioSniper.

What is the prevalence of Ann Arbor Stage I Hodgkin Lymphoma?

The estimated prevalence of Ann Arbor Stage I Hodgkin Lymphoma is approximately 56.0 per 100,000 population.

Deep-dive into Ann Arbor Stage I Hodgkin Lymphoma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Ann Arbor Stage I Hodgkin Lymphoma — Drugs in Development & Clinical Trials | BioSniper